A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
NCT06798207
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
170
Enrollment
INDUSTRY
Sponsor class
Conditions
Gynecological Tumors
Interventions
DRUG:
TQB2102 for injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.